Dasatinib Monohydrate with CAS No:863127-77-9 is an impurity standard of Dasatinib.
Dasatinib is a tyrosine kinase inhibitor used in the treatment of certain types of cancer, notably chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by inhibiting the activity of specific tyrosine kinases, including BCR-ABL, which is a fusion protein associated with CML and Ph+ ALL. By blocking these signaling pathways, dasatinib helps to inhibit the proliferation and survival of cancer cells. Dasatinib is typically administered orally and has demonstrated efficacy in patients who are resistant or intolerant to other tyrosine kinase inhibitors. As with any cancer treatment, its use is determined by the patients specific diagnosis and the recommendations of healthcare professionals.
Buy high quality Dasatinib Monohydrate from from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Dasatinib Monohydrate

Dasatinib Monohydrate

CAT. No. CP-D1008
CAS. No. 863127-77-9
Mol. F. C22H26ClN7O2S : H2O
Mol. Wt. 488 : 18.0
Stock Status In Stock
Rel. Cas No 302962-49-8 (free base) ; 854001-07-3 (HCl salt)
VIEW COA Sample PDF

Product Description


  • Category:Impurity Standards
  • Synonyms:NA
  • Chemical Name:N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide hydrate

Request for Quotation : Dasatinib Monohydrate

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...